New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
New York—After several poor years, the biotechnology industry rebounded in 2013 with 45 initial public offerings (IPOs) of biotechnology companies and more money flowing into the sector. It was the most activity in the sector since 2000, and...
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Researchers argue that public funding efforts should be invested in improving the use of patient centered medical homes for children covered under public insurance, or those who have no insurance at all.
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
Authors noted that enrollment in high deductible health plans “was associated with minimal or no reductions in controller medication use for children and adults and no change in asthma exacerbations,” suggesting a potential benefit from...
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
There are many educational efforts designed to increase the rates of screening for cancer, which is an important part of standard medical care. However, the balance of the risks and benefits of screening are affected by situations such as...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.